Fibrin Sealants Market Size & Share, by Type (Liquid, Patch, Powder); Application (General Surgery, Cardiovascular Surgery, Thoracic Surgery, Orthopedic Surgery, Transplant Surgery, Neurosurgery, Dental Surgery, Wound Management); Technology (Autologous Donation, Viral Inactivation, Recombinant Production); End-user (Hospitals, Ambulatory Surgical Centers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

Request Free Sample Copy

Report ID: 4466
Published Date: Feb 24, 2023
Report Format: PDF, PPT

Buy Now

Companies Dominating the Fibrin Sealants Landscape

CSL Limited
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Baxter International, Inc.
Pfizer Inc.
Asahi Kasei Corporation
Vivostat A/S
Octapharma AG

Browse Key Market Insights with Data Illustration:

Fibrin Sealants Market Size & Share | Growth Trends 2033

In the News

Asahi Kasei Corporation has acquired Bionova Scientific, LLC, a provider of contract process development and GMP-compliant contract manufacturing services to the biopharmaceutical industry.
Grifols S.A. launched VISTASEAL plasma-protein-based bleeding-control solutions. Using Ethicon's airless spray device technology, this medication combines fibrinogen and thrombin, two plasma proteins.

Frequently Asked Questions (FAQ)

Worldwide growing count of surgical procedures, upsurge in hemophilia cases, spiking numbers of orthopedic surgeries, and worldwide increase in geriatric population are some major factors driving the growth of the market.

The market is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2023-2033.

Associated limitations of fibrin sealants in minimally invasive surgeries, delay of surgeries as of COVID-19 restrictions, and stringent government policies for approval of sealants are estimated to hamper the market growth.

The market in North America is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are CSL Limited, Baxter International, Inc., Pfizer Inc., Asahi Kasei Corporation, Vivostat A/S, Octapharma AG, and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by type, application, technology, end-user, and by region.

The cardiovascular surgery segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.

Companies Dominating the Fibrin Sealants Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What are the major factors driving the growth of the fibrin sealants market?

What would be the CAGR of fibrin sealants market over the forecast period?

What are the challenges affecting the fibrin sealants market growth?

Which region will provide more business opportunities for growth of fibrin sealants market in future?

Who are the major players dominating the fibrin sealants market?

How are the company profiles selected?

What are the segments in the fibrin sealants market?

Which segment captures the largest market size in application segment in the fibrin sealants market?